IP Library Assignment 015629/0561
Patent Assignment
Reel/Frame 015629/0561

Merger/Change of Name

Recorded: 2005-01-31 Pages: 19
Assignor
NEURONZ LIMITED
Executed: 2004-05-21
Assignee
ENDOCRINZ LIMITED
LEVEL 3, 2-6 PARK AVENUE, GRAFTON, AUCKLAND, NEW ZEALAND
Covered Properties (37)
New Peptide Antagonists at Glutamate and Nmda Receptors
Patent: 5,804,550 →
Application: 08/549,798 →
Composition and Methods to Improve Neural Outcome
Application: 08/656,331 →
Composition Amd Methods to Improve Neural Outcome
Application: 08/907,918 →
Regulation of Neural Enzymes
Patent: 6,365,573 →
Application: 09/269,907 →
Methods to Improve Neural Outcome
Patent: 6,187,906 →
Application: 09/332,868 →
Neuronal Rescue Agent
Application: 09/508,897 →
Regulation of Tyrosine Hydroxylase
Patent: 6,617,311 →
Application: 09/719,459 →
Neuroprotective Effect of Growth Hormone
Patent: 7,304,029 →
Application: 09/786,982 →
Methods to Improve Neural Outcome
Patent: 6,812,208 →
Application: 09/866,536 →
Publication: US 2002/0035066
Use of Gpe to Protect Glial Cells or Non-Dopaminergic Cells from Death from Neural Injury or Disease
Patent: 6,780,848 →
Application: 09/910,461 →
Publication: US 2002/0013277
Compositions and methods for the rescue of white matter
Application: 10/013,812 →
Publication: US 2003/0027755
GLY-PRO-GLU DECREASES GnRH RELEASE
Application: 10/087,011 →
Publication: US 2002/0115594
Methods for Promoting Weight Gain Using Gpe-Related Compounds
Patent: 6,682,753 →
Application: 10/099,134 →
Publication: US 2002/0151522
Anti-GPE antibodies, their uses, and analytical methods for GPE
Application: 10/100,515 →
Publication: US 2002/0177239
Composition and methods to improve neural outcome
Application: 10/119,386 →
Publication: US 2003/0027760
Gpe Analogs and Peptidominetics
Patent: 7,041,314 →
Application: 10/155,864 →
Publication: US 2003/0055004
Neuronal rescue agent
Application: 10/157,542 →
Publication: US 2003/0060398
Methods of providing neuroprotection and/or neurorestoration via the neural activin type IIB receptor
Application: 10/177,735 →
Publication: US 2003/0103959
Neural Regeneration Peptides and Methods for Their Use in Treatment of Neural Injury or Degeneration
Patent: 7,767,786 →
Application: 10/225,838 →
Publication: US 2003/0211990
Gpe Analogs
Patent: 7,112,570 →
Application: 10/362,266 →
Publication: US 2004/0014674
Treatment of Demyelinating Diseases
Patent: 7,192,931 →
Application: 10/398,876 →
Publication: US 2004/0053850
Functional proteomics using double phage display screening
Application: 10/433,738 →
Publication: US 2004/0053218
Regulation of Tyrosine Hydroxylase by Gpe
Patent: 6,933,282 →
Application: 10/606,574 →
Publication: US 2004/0087487
Compositions and methods for the rescue of white matter
Application: 60/254,349 →
Regulation of weight
Application: 60/278,562 →
Compositions and methods for the resuce of white matter
Application: 60/287,668 →
Methods of providing neuroprotection and/or neurorestoration via the neural type IIB activin receptor (Act RIIB)
Application: 60/300,514 →
Compositions and methods for the treatment of brain damage
Application: 60/314,952 →
Compositions and methods for immunomodulation
Application: 60/370,788 →
Cyclic proline-containing peptide mimics
Application: 60/456,136 →
Neuroprotective macrocyclic compounds and methods for their use
Application: 60/505,119 →
Pharmacokinetics of GPE and methods of administration
Application: 60/515,397 →
Neural regeneration peptides and methods for their use
Application: 60/516,018 →
Neuroprotective effects of gly-pro-glu following intravenous infusion
Application: 60/553,688 →
GPE and GPE analogues/peptidomimetics and caffeinol improve sensory-motor functional recovery after stroke in rat
Application: 60/557,940 →
GPE and G2MePE in combination with caffeinol improve sensory motor functional recovery after stroke
Application: 60/572,627 →
Neural regeneration peptides: a new class of chemoattractive and neuronal survival promoting proteins
Application: 60/585,041 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 3, 2001
From: GLUCKMAN, PETER D.; WILLIAMS, CHRISTOPHER E.; GUAN, JIAN; KRISHNAMURTHI, RITA V.M.
To: NEURONZ LIMITED
Reel/Frame 012331/0703 →
Assignment of Assignor's Interest Apr 27, 2004
From: AUCKLAND UNISERVICES LIMITED
To: NEURONZ LTD
Reel/Frame 014569/0309 →
Assignment of Assignor's Interest Dec 27, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015494/0571 →
Assignment of Assignor's Interest Dec 27, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS, LTD.
Reel/Frame 015494/0587 →
Assignment of Assignor's Interest Dec 27, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015494/0704 →
Assignment of Assignor's Interest Dec 27, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015500/0648 →
Assignment of Assignor's Interest Dec 27, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015501/0745 →
Assignment of Assignor's Interest Dec 27, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015500/0155 →
Assignment of Assignor's Interest Dec 27, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015501/0643 →
Assignment of Assignor's Interest Dec 28, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015494/0784 →
Assignment of Assignor's Interest Dec 28, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015494/0805 →
Assignment of Assignor's Interest Dec 29, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015508/0722 →
Assignment of Assignor's Interest Dec 29, 2004
From: NEURONZ LTD.
To: NEUEN PHARMACEUTICALS LTD.
Reel/Frame 015503/0610 →
Assignment of Assignor's Interest Dec 29, 2004
From: NEURONZ, LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015504/0807 →
Assignment of Assignor's Interest Dec 29, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015507/0864 →
Assignment of Assignor's Interest Dec 29, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015508/0666 →
Assignment of Assignor's Interest Dec 29, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015508/0790 →
Assignment of Assignor's Interest Dec 29, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015508/0806 →
Assignment of Assignor's Interest Dec 29, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015508/0822 →
Assignment of Assignor's Interest Dec 30, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015511/0428 →
Assignment of Assignor's Interest Dec 30, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015514/0966 →
Assignment of Assignor's Interest Dec 30, 2004
From: NEURONZ, LTD.
To: NEUREN PHARMACEUTICALS, LTD.
Reel/Frame 015509/0505 →
Assignment of Assignor's Interest Dec 30, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015511/0251 →
Assignment of Assignor's Interest Dec 30, 2004
From: NEURONZ LTD.
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015511/0358 →
Assignment of Assignor's Interest Jan 25, 2005
From: GLUCKMAN, PETER DAVID; ALEXI, TAJRENA
To: NEUREN PHARMACEUTICALS LTD.
Reel/Frame 015620/0337 →